Tresiba

Before taking this medicine

Do not use Tresiba during an episode of low blood sugar (hypoglycemia), or if you are allergic to insulin degludec or any of its ingredients. Low blood sugar can be life-threatening. Closer blood glucose monitoring is needed if your insulin treatment, other medicines, meal pattern or physical activity changes, or if you have kidney or liver impairment or do not recognise the signs of low blood sugar. Changes to your insulin treatment, injection site or injection method should be made under close medical supervision, as they may cause high or low blood sugar. Check the insulin label before every injection to avoid mix-ups. Never share a Tresiba pen or needles, even if the needle is changed. Do not transfer insulin from the pen into a syringe, as this can cause an overdose and severe low blood sugar. Severe allergic reactions, including life-threatening anaphylaxis, can occur. Stop using Tresiba and seek immediate medical help if a severe allergic reaction occurs. Tresiba can also cause dangerously low potassium levels; people at risk may need potassium monitoring. Taking Tresiba with thiazolidinediones (TZDs) may cause fluid retention and heart failure and requires monitoring for signs of heart failure.